Allogene Therapeutics Inc... (ALLO)
1.80
-0.15 (-7.69%)
At close: Mar 03, 2025, 3:59 PM
1.79
-0.56%
After-hours: Mar 03, 2025, 07:09 PM EST
Allogene Therapeutics Revenue
Allogene Therapeutics reported an annual revenue of $95K, reflecting a -60.91% growth. For the quarter ending September 30, 2024, Allogene Therapeutics generated $0 in revenue.
Revenue (ttm)
$95K
Revenue Growth
-60.91%
Price / Sales Ratio
5302.64
Revenue / Employee
$409.48
Employees
232
Market Cap
377.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 95K | -60.91% |
| Dec 31, 2022 | 243K | -99.37% |
| Dec 31, 2021 | 38.49M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |